Your browser doesn't support javascript.
Symptoms in patients with asthma infected by SARS-CoV-2.
Garcia-Pachon, Eduardo; Ruiz-Alcaraz, Sandra; Baeza-Martinez, Carlos; Zamora-Molina, Lucia; Soler-Sempere, Maria J; Padilla-Navas, Isabel; Grau-Delgado, Justo.
  • Garcia-Pachon E; Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain. Electronic address: egpachon@gmail.com.
  • Ruiz-Alcaraz S; Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain.
  • Baeza-Martinez C; Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain.
  • Zamora-Molina L; Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain.
  • Soler-Sempere MJ; Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain.
  • Padilla-Navas I; Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain.
  • Grau-Delgado J; Section of Respiratory Medicine, Hospital General Universitario de Elche, Elche, Alicante, Spain.
Respir Med ; 185: 106495, 2021.
Article in English | MEDLINE | ID: covidwho-1260857
ABSTRACT

INTRODUCTION:

Organ tropism of SARS-CoV-2 to the respiratory tract could potentially aggravate asthma. The susceptibility of patients with asthma to develop an exacerbation when they are infected with SARS-CoV-2 is unknown. We aimed to investigate the symptoms presented in patients with asthma who became infected with SARS-CoV-2. METHODS AND

RESULTS:

All patients over 14 years of age who tested positive for SARS-CoV-2 (by RT-PCR) were included (n = 2995). In patients with asthma (n = 77, 2.6%; 44 females), symptoms, therapy and phenotype were recorded. Seventeen (22%) patients had mild asthma, 55 (71%) moderate and five severe (6%). Twenty-six patients with asthma (34%) were asymptomatic, 34 (44%) developed symptoms but did not require hospital admission, and 17 (22%) were hospitalised. One patient was admitted because of asthma exacerbation without pneumonia or other symptoms. Ten patients (13%) had wheezes (six with pneumonia). Comparison of wheezing between patients with non-T2 asthma and the rest of the patients was statistically significant, (p < 0.001).

CONCLUSIONS:

SARS-CoV-2 infection is not a significant cause of asthma exacerbation, although some patients may present wheezing, especially in cases of pneumonia. The severity of asthma does not seem to be associated with symptoms of the disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Respir Med Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Asthma / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Observational study / Prognostic study Limits: Adult / Female / Humans / Male / Middle aged Language: English Journal: Respir Med Year: 2021 Document Type: Article